esophageal cancer

Showing 1 - 25 of 805

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oral Cancer, Esophageal Cancer, Larynx Cancer Trial (Narrative pictorial warning labels for alcoholic beverages, Non-narrative

Not yet recruiting
  • Oral Cancer
  • +3 more
  • Narrative pictorial warning labels for alcoholic beverages
  • Non-narrative pictorial warning labels for alcoholic beverages
  • (no location specified)
Nov 8, 2023

Online Adaptive Radiotherapy UsingNovel Linear Accelerator

Recruiting
  • Prostate Cancer
  • +8 more
  • Online adaptive radiation therapy
  • Berlin, Germany
    Charité - Universitätsmedizin
Oct 30, 2023

Esophageal Cancer, Gastric Cancer Trial in Worldwide (Surveillance protocol)

Not yet recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Surveillance protocol
  • Cologne, Germany
  • +12 more
Oct 29, 2023

Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Esophageal Cancer
  • +10 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Prevent Anastomotic Leakage After Esophagectomy Due to

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Eso-SPONGE®
  • Barcelona, Catalunya, Spain
    Hospital Clinic de Barcelona
Oct 20, 2023

Hypoxia, Gastric Polyp, Colon Cancer Trial in China (the COMBO Endoscopy Oropharyngeal Airway, Regular Nasal Cannula)

Not yet recruiting
  • Hypoxia
  • +3 more
  • the COMBO Endoscopy Oropharyngeal Airway
  • Regular Nasal Cannula
  • Nanjing, Jiangsu, China
  • +5 more
Oct 7, 2023

G-POEM for Refractory Gastroparesis After Esophagectomy With

Not yet recruiting
  • Gastroparesis
  • Esophageal Cancer
    • (no location specified)
    Oct 3, 2023

    Esophageal Cancer Trial in Tianjin (Arm A, Arm B)

    Not yet recruiting
    • Esophageal Cancer
    • Arm A
    • Arm B
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital
    Sep 24, 2023

    Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

    Active, not recruiting
    • Esophageal Cancer
    • follow up
    • Guangzhou, Guangdong, China
      Jianhua Fu
    Sep 24, 2023

    Endoscopic Submucosal Dissection Versus Esophagectomy for Early

    Completed
    • Esophageal Cancer
    • Endoscopic submucosal dissection
    • Esophagectomy
    • Shanghai, China
      Changhai Hospital, Naval Medical University
    Sep 27, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Esophageal Cancer Trial in Ramat Gan (CPAP)

    Recruiting
    • Esophageal Cancer
    • CPAP
    • Ramat Gan, Israel
      Sheba Medical Center
    Sep 13, 2023

    Esophageal Cancer, Esophageal Tumors Trial in Boston (Prehabilitation Program)

    Not yet recruiting
    • Esophageal Cancer
    • Esophageal Neoplasms
    • Prehabilitation Program
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Esophageal Cancer Trial in Guangzhou (Submucosal Saline Injection, Blue laser Imaging and Magnifying Endoscopy)

    Recruiting
    • Esophageal Cancer
    • Submucosal Saline Injection
    • Blue laser Imaging and Magnifying Endoscopy
    • Guangzhou, Guangdong, China
      Cancer center, Sun Yat-sen University
    Aug 28, 2023

    Patient Participation in Lung and Esophageal Cancer Patients

    Recruiting
    • Lung Cancer
    • Esophageal Cancer
      • Guangzhou, China
        Sun Yat-sen University
      Aug 25, 2023

      Symptoms Based on Patient-reported Outcomes in Immunotherapy for

      Not yet recruiting
      • Esophageal Cancer
      • +2 more
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Aug 24, 2023

        Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)

        Recruiting
        • Gastric Cancer
        • +6 more
        • CEA-targeted CAR-T cells
        • Taiyuan, Shanxi, China
        • +1 more
        Aug 24, 2023

        Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

        Not yet recruiting
        • Esophageal Cancer
        • +2 more
        • (no location specified)
        Aug 21, 2023

        Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

        Not yet recruiting
        • Esophageal Cancer
        • +2 more
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Aug 22, 2023

        Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

        Recruiting
        • Esophageal Squamous Cell Carcinoma
        • +2 more
        • LDRT+CFRT
        • +2 more
        • Shanghai, China
        • +1 more
        Aug 3, 2023

        Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

        Not yet recruiting
        • Esophageal Cancer
        • +3 more
        • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
        • Edegem, Belgium
          Antwerp University Hospital
        Jul 19, 2023

        Esophageal Cancer, Active Surveillance, Neoadjuvant Chemoradiotherapy Trial in Rotterdam (Active surveillance)

        Active, not recruiting
        • Esophageal Cancer
        • +3 more
        • Active surveillance
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus MC, University Medical Center
        Jul 11, 2023

        Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

        Not yet recruiting
        • Esophageal Cancer
        • +3 more
        • Beijing, Beijing, China
          Department of Radiation Oncology, Cancer Institute and Hospital,
        Jul 12, 2023

        Lung Cancer, Head Neck Cancer, Esophageal Cancer Trial in Seoul (Fitbit smartwatch)

        Recruiting
        • Lung Cancer
        • +2 more
        • Fitbit smartwatch
        • Seoul, Gangnamgu, Korea, Republic of
          Samsung Medical Center
        Jun 30, 2023